News

The Trump administration is expected to release an executive order this week that mandates the disclosure of healthcare prices across the industry, The Wall Street Journal reported. If enacted, the executive order could turn the traditionally opaque healthcare industry on its head.

Members of the American Medical Group Association (AMGA), which represents more than 175,000 physicians, are bullish on taking on risk, with more member revenues coming from risk-based models in 2018, according to a recent survey on the transition to value-based care.

HHS has named a new chief information officer, Jose Arrieta. The position had been open for about nine months.

Two of the leading causes of death have had opposite trajectories in the U.S. over the last two decades, despite sharing similar lifestyle and health-risk factors.

The overall cost of care for Medicare fee-for-service beneficiaries is 16.7% higher than Medicare Advantage beneficiaries when it comes to caring for dual eligible beneficiaries, according to a recent report from Avalere.

The promised, less expensive insulin product from pharmaceutical company Eli Lilly has officially come to market, the company announced May 22.

The percentage of individuals offered access to their online medical record did not change from 2017 to 2018, according to the Office of the National Coordinator for Health Information Technology (ONC).

Political unrest isn’t taking much of a toll on deals in healthcare, with executives still bullish on the sector, according to new data from Merrill Corp.

A Google-affiliated company is taking on clinical trials with the pharmaceutical industry, CNBC reported. The health and life sciences business of Google’s parent company Alphabet has launched strategic alliances with Novartis, Sanofi, Otsuka and Pfizer to work in the medical studies space.

Together, private health insurance, Medicare and Medicaid accounted for 82% of total prescription drug spending in the U.S. in 2017, according to a recent analysis from the Kaiser Family Foundation that broke down drug spending that year.

Consumer goods giant Nestlé is in talks to sell its skin health business to private equity firm EQT and the Abu Dhabi Investment Authority for $10.1 billion, The Wall Street Journal reported.

National health spending reached $3.76 trillion in March 2019, a 4.6% jump from the same month in 2018, according to recent data from Altarum, underscoring signs of acceleration during the first quarter of 2019.